# to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

Study · id `cardio:ct-nct02056847` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02056847](<https://clinicaltrials.gov/study/NCT02056847>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02056847

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 313 participants.

## Technical summary

Registry record NCT02056847. Randomized; no masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2017-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 313 participants (enrolled count; ClinicalTrials.gov record NCT02056847, source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)
- Started: 2013-09 (actual) (ClinicalTrials.gov record NCT02056847, source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)
- Primary completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02056847, source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)
- Completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02056847, source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02056847, source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02056847-2018-03-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
- Acronym: SIPHON
- Condition: HbA1c Level Associated With Lipid Compositions
- Intervention (Drug): Pitavastatin calcium 4mg
- Intervention (Drug): Pitavastatin calcium 2mg
- Lead sponsor: JW Pharmaceutical
- Lead sponsor class: INDUSTRY
- Collaborator: The Catholic University of Korea
- Collaborator class: OTHER
- Collaborator: Kyunghee University Medical Center
- Collaborator class: OTHER
- Collaborator: Korea University Guro Hospital
- Collaborator class: OTHER
- Collaborator: Dong-A University Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER
- Collaborator: Samsung Medical Center
- Collaborator class: OTHER
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: Ajou University School of Medicine
- Collaborator class: OTHER
- Collaborator: Gangnam Severance Hospital
- Collaborator class: OTHER
- Collaborator: Severance Hospital
- Collaborator class: OTHER
- Collaborator: Yeungnam University Hospital
- Collaborator class: OTHER
- Collaborator: Ulsan University Hospital
- Collaborator class: OTHER
- Collaborator: Eulji University Hospital
- Collaborator class: OTHER
- Collaborator: Asan Medical Center
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Chonbuk National University Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Hallym University Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Pitavastatin (`cardio:pitavastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 18 registry organizations

## Provenance

Content hash: 5736ceda85135d1bb54623b2e48aac61310f51ffeec2dc6f51fd2cdc3f2ad1b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
